Cargando…
Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
INTRODUCTION: Epithelial-mesenchymal transition (EMT) is a process of transdifferentiation where epithelial cells attain mesenchymal phenotype to gain invasive properties and thus, can contribute to metastasis of tumor cells. OBJECTIVES: The antimetastatic and antitumor efficacy of brusatol (BT) was...
Autores principales: | Lee, Jong Hyun, Mohan, Chakrabhavi Dhananjaya, Deivasigamani, Amudha, Jung, Young Yun, Rangappa, Shobith, Basappa, Salundi, Chinnathambi, Arunachalam, Alahmadi, Tahani Awad, Alharbi, Sulaiman Ali, Garg, Manoj, Lin, Zhi-Xiu, Rangappa, Kanchugarakoppal S., Sethi, Gautam, Hui, Kam Man, Ahn, Kwang Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584682/ https://www.ncbi.nlm.nih.gov/pubmed/33133685 http://dx.doi.org/10.1016/j.jare.2020.07.004 |
Ejemplares similares
-
3-Formylchromone Counteracts STAT3 Signaling Pathway by Elevating SHP-2 Expression in Hepatocellular Carcinoma
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2021) -
The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells
por: Lee, Jong Hyun, et al.
Publicado: (2019) -
N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway
por: Mohan, Chakrabhavi Dhananjaya, et al.
Publicado: (2018) -
Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) Abrogates Tumor Progression in Hepatocellular Carcinoma and Multiple Myeloma Preclinical Models by Regulating the STAT3 Signaling Pathway
por: Arora, Loukik, et al.
Publicado: (2021) -
Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma
por: Lee, Jong Hyun, et al.
Publicado: (2019)